Cafepharma Today

January 27 2025 - Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
Metsera eyes $289M IPO to fund phase 3 weight loss trial
Biogen, Eisai win nod for monthly Leqembi maintenance amid stagnant sales
Sara Brenner, FDA device official, named agency’s acting head
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Biogen Earnings Rise, Matching Estimates
TheStreet.com
Friday, February 6, 2009 - 8:21am
tags:
Biogen Idec, earnings
Fertility Drugs and Ovarian Cancer Not Linked, Study Says
NY Times, NY
Friday, February 6, 2009 - 7:27am
tags:
fertility drugs, ovarian cancer
Biotechnology: The New Defensive Sector That's Set to Rise?
Seeking Alpha
Friday, February 6, 2009 - 7:24am
tags:
biotech, metabolic syndrome, vaccines, infection diseases
Roche Seeks Biotech Licensing, Takeovers in China
Bloomberg
Friday, February 6, 2009 - 6:11am
tags:
Roche, China
Sequenom recovers from two-day stumble
Yahoo/AP
Friday, February 6, 2009 - 6:10am
tags:
Sequenom, Downs Syndrome
Vertex CEO To Give Up Post in May
WSJ Online
Friday, February 6, 2009 - 6:09am
tags:
Vertex Pharmaceuticals, Pharma CEOs
J&J seeks full FDA approval for HIV treatment
Yahoo/AP
Thursday, February 5, 2009 - 5:19pm
tags:
FDA, JNJ, HIV, Tibotec
Biotech Stock Roundup: Amylin Ascends
TheStreet.com
Thursday, February 5, 2009 - 5:16pm
tags:
Amylin, Dendreon, Medivation, Elan, Genzyme, Biogen Idec, Genentech, Amgen, Gilead Sciences
Earnings Preview: Biogen Idec
Seeking Alpha
Thursday, February 5, 2009 - 5:14pm
tags:
earnings, Biogen Idec
King Pharmaceuticals Offers New Dosage Strengths of AVINZA to Provide More Treatment Options for People with Chronic Pain
Yahoo
Thursday, February 5, 2009 - 5:13pm
tags:
King, chronic pain, Avinza
Merck Enters Challenging Period
Yahoo/Zacks.com
Thursday, February 5, 2009 - 5:10pm
tags:
Merck, Pfizer
[video] Cramer Interviews Allergan CEO
TheStreet.com
Thursday, February 5, 2009 - 10:28am
tags:
Allergan, earnings, Pharma CEOs
Crucell posts 4Q profit on vaccine sales
Yahoo/AP
Thursday, February 5, 2009 - 10:27am
tags:
vaccines, Crucell, earnings
A Magic Formula Stock to Avoid: Maxygen (MAXY)
Motley Fool
Thursday, February 5, 2009 - 10:14am
tags:
Maxygen
Bullish Thesis for Biotech Remains Intact
Seeking Alpha
Thursday, February 5, 2009 - 10:02am
tags:
biotech, Cypress Bioscience, Forest Labs, Geron, Repros Therapeutics, Myriad Genetics
Prempro, Breast Cancer and ‘Post Hoc Ergo Propter Hoc’
WSJ Online
Thursday, February 5, 2009 - 10:00am
tags:
breast cancer, Prempro, HRT, Wyeth
Biotech Stocks: Survival of the Fittest
Businessweek
Thursday, February 5, 2009 - 9:58am
tags:
biotech, Genentech, Roche, buyouts
GlaxoSmithKline Q4 profit dips, confirms job cuts
Yahoo/AP
Thursday, February 5, 2009 - 8:08am
tags:
GSK, earnings, layoffs
Dr. Reddy's Announces Five ANDA Approvals and Generic Product Launches in the US Market
Yahoo
Thursday, February 5, 2009 - 7:19am
tags:
Dr Reddy's, generics, Keppra, Prilosec, Lamictal, Depakote
NovaDel Pharma: Won't Be Long Before Big Pharma Partners Come Calling
Seeking Alpha
Thursday, February 5, 2009 - 7:16am
tags:
NovaDel, Big Pharma, buyouts, Zolpimist, insomnia

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels
2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline

Latest Jobs

Onsite Endoscopic Specialist - Operating Room Support
Santa Monica, California
KARL STORZ Endoscopy - America
Area Manager, Immunology Rochester, NY Territory
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Tarrytown, NY
Tarrytown, New York
Lundbeck
Area Manager Specialty, West- Central
Fields, Oregon, 97710
CSL Behring
Area Sale Manager, Immunology Tampa North
Fields, Oregon, 97710
CSL Behring
Sales Representative
Boise, Idaho, 83708
Bartlett Roofing
Capital Project Manager
Carteret, New Jersey, United States
The Spear Group
Area Manager Specialty, West
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Midland, TX
Midland, Texas, 79701
Lundbeck
Home Health and Medical Sales
The Woodlands, Texas, 77381
Comfort Keepers of Dallas TX
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information